 |
Recommend Products |
 |
|
|
|
 |
Hot Keywords |
|
 |
 1,1,1-Trifluoro-2-iodoethane | 1-Iodohexane | 1-Iodohexadecane | 1-Iodoheptane | | 1-Chloro-2-iodoethane | 1-Bromo-4-iodobenzene | 1-Bromo-3-iodobenzene | 1-Bromo-2-iodobenzene | | 1-Aminopyridinium iodide | [Bis(trifluoroacetoxy)iodo]benzene | (E)-Methyl-3-iodoacrylat3 | (Dichloroiodo) benzene | | (2-Iodoethyl)benzene | (2-Acetyl-4-methylpentyl)trimethylammonium iodide | Thymol iodide | Isopropamide iodide | | Ethyl 5-Aminobenzofuran-2-Carboxylate | BGB-324;R428 | ND-630 | Allotetrahydroprogesterone; Allopregnanolone; LJPC-0712; SAGE-547; | | IT-901 | RuCl((R,R)-pentafluorophenylsulfonyl-DPEN)(p-cymene) | Tropifexor; LJN-452 | PQR530 | | AZD-4635; HTL-1071 | LX-2761 intermediate | MSC2530818 | Verucerfont; GSK561679; NBI77860 | | MTX-211 | MAK683 | GSK-2018682 | E-7046 | | PX-102; PX-20606 | 7-benzocycloheptanone | CPI-444; V81444 | Veliparib; ABT-888; NSC-737664 | | Erlotinib Hydrochloride; Tarceva | Dacomitinib; PF-00299804; PF-299; PF-299804; PF-804; PF-00299804-03; PF-00299804-3 | Neratinib; HKI-272; PB-272; PF-0528767; WAY-179272 | Olmutinib; Olita | | Lapatinib Ditosylate Monohydrate | Vandetanib | Revefenacin; TD-4208; GSK-1160724 | 2-chloro-4-methoxybenzo[d]thiazole | | BAY-1895344 | Mirogabalin besylate | ARQ-087 | GSK-2816126 | | EPZ-6438; Tazemetostat | AZD-3759 | (S)-4-bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | (Z)-N-(4-bromo-2,3-dihydro-1H-inden-1-ylidene)-2-methylpropane-2-sulfinamide | | N-((S)-4-bromo-2,3-dihydro-1H-inden-1-yl)-2-methylpropane-2-sulfinamide | methyl (diethoxyphosphoryl)formate | (R)-benzyl (2-oxoazepan-3-yl)carbamate | Retagliptin; SP-2086 | | GSK2982772 | GSK2256098; GTPL7939 | 2-(1-(6-chloro-2,5-dimethylpyrimidin-4-yl)piperidin-4-yl)-1,5,6,7-tetrahydro-1,8-naphthyridine | 2-(piperidin-4-yl)-1,5,6,7-tetrahydro-1,8-naphthyridine | | tert-butyl 4-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)piperidine-1-carboxylate | tert-butyl 4-(1,8-naphthyridin-2-yl)piperidine-1-carboxylate | 4,6-dichloro-2,5-dimethylpyrimidine | (S)-7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-amine | | 3-hydrazono-3,5,6,7-tetrahydro-2H-benzo[6,7]cyclohepta[1,2-c]pyridazine | 6,7-dihydro-2H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3(5H)-one | 4a,5,6,7-tetrahydro-2H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3(4H)-one | 2-(5-oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulen-6-yl)acetic acid | | N-(2-((6-(2-(2,6-dichloro-3,5-dimethoxyphenyl)-N-methyl-3-(2-(trimethylsilyl)ethoxy)propanamido)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)acrylamide | 1-(6-((2-amino-4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methyl-3-((2-(trimethylsilyl)ethoxy)methyl)urea | 1-(2,6-dichloro-3,5-dimethoxyphenyl)-3-(6-((4-(4-ethylpiperazin-1-yl)-2-nitrophenyl)amino)pyrimidin-4-yl)-3-methyl-1-((2-(trimethylsilyl)ethoxy)methyl)urea | 1-(6-chloropyrimidin-4-yl)-3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methyl-3-((2-(trimethylsilyl)ethoxy)methyl)urea | | 1-(6-chloropyrimidin-4-yl)-3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylurea | 2,4-dichloro-3-isocyanato-1,5-dimethoxybenzene | 2,6-dichloro-3,5-dimethoxyaniline | N-(2,6-dichloro-3,5-dimethoxyphenyl)acetamide | | N-(3,5-dimethoxyphenyl)acetamide | 4-(4-ethylpiperazin-1-yl)-2-nitroaniline | tert-butyl (4-(4-ethylpiperazin-1-yl)-2-nitrophenyl)carbamate | 6-chloro-N-methylpyrimidin-4-amine | | (R)-N-(1-(azepan-3-yl)-7-chloro-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide | (R)-tert-butyl 3-(7-chloro-2-(2-methylisonicotinamido)-1H-benzo[d]imidazol-1-yl)azepane-1-carboxylate | (R)-tert-butyl 3-(2-amino-7-chloro-1H-benzo[d]imidazol-1-yl)azepane-1-carboxylate | IPI-549 | | FGF401 | Mirogabalin; DS-5565 | (4aS,6aR,6bS,8aR,12aR,14bS)-methyl 11-bromo-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicene-4a-carboxylate | EED226 | | Mivebresib; ABBV-075 | (Z)-3-((4,5,6,7-tetrahydro-1H-indol-2-yl)methylene)indolin-2-one | N-(furan-2-ylmethyl)-8-(4-(methylsulfonyl)phenyl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine | (R)-tert-butyl 3-aminoazepane-1-carboxylate | | BAR 501 impurity | Bardoxolone; RTA 402; CCDO | PF-06840003 | GLPG0187 | | EAI045 | 1-amino-4-bromo-2-naphthonitrile | 1-amino-2-naphthonitrile | (2-aminophenyl)dimethylphosphine oxide | |
|
|
